# Propanc Biopharma, Inc.: Form 8-K, filed Dec 16, 2014

- Company: [Propanc Biopharma, Inc.](/companies/ppcb.md) (CIK 1517681)
- Form: 8-K
- Filed: 2014-12-16
- Accepted by EDGAR: Dec 16, 2014, 07:21 ET
- Period: 2014-11-12
- Accession: 0001144204-14-074117
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1517681/000114420414074117/v396665_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1517681/000114420414074117/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1517681/000114420414074117/v396665_8k.htm

Filed Dec 16, 2014.
Source: SEC EDGAR, the filing index for accession 0001144204-14-074117. Last ingested by Listed: Oct 29, 2026, 17:01 ET. No prices; not investment advice.